124 related articles for article (PubMed ID: 3025113)
1. Lung function improvement, tremor measurements and c-AMP determinations in a group of ten patients with asthmatic bronchitis after one week sustained release theophylline medication (theophylline plasma level +/- 10 mg/l) compared to one week placebo.
Van der Vet AP; Kreukniet J; Drost RH; Maes RA; Fokkens JK; Hamelink ML
Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):638-42. PubMed ID: 3025113
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics (lung function tests, tremor measurements and cAMP determinations) of a single dose of 0.5 mg terbutaline subcutaneously during sustained-release theophylline medication in patients with asthmatic bronchitis.
van der Vet AP; Kreukniet J; Drost RH; Maes RA; Fokkens JK; Hamelink ML
Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):569-73. PubMed ID: 3023243
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy of theophylline and terbutaline as sustained-release preparations in patients with asthmatic bronchitis.
van der Vet AP; Kreukniet J; van Drost RH; Maes RA; Fokkens JK; Hamelink MJ
Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):558-64. PubMed ID: 2828249
[TBL] [Abstract][Full Text] [Related]
4. Terbutaline sustained-release treatment during one week 5 mg b.i.d. compared to one week placebo: terbutaline plasma levels, c-AMP plasma levels, lung function and tremor measurement.
van der Vet AP; Kreukniet J; Drost RH; Maes RA; Fokkens JK; Hamelink ML
Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):609-12. PubMed ID: 2828250
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung function.
van der Vet AP; Kreukniet J; Drost RH; Maes RA
Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):339-44. PubMed ID: 4030161
[TBL] [Abstract][Full Text] [Related]
6. [The anti-inflammatory action of an oral sustained-release theophylline preparation. Results of a clinical pilot study with low dosages].
Bodner A; Hens C; Moser C; Oster H
Arzneimittelforschung; 1998 May; 48(5A):617-24. PubMed ID: 9676355
[TBL] [Abstract][Full Text] [Related]
7. Sustained-release theophylline in chronic bronchitis.
Anderson G; Peel ET; Pardoe T; Jones R
Br J Dis Chest; 1982 Jul; 76(3):261-5. PubMed ID: 6751366
[TBL] [Abstract][Full Text] [Related]
8. [The effect of protheo on pulmonary function and the change of its plasma concentration in patients with chronic asthmatic bronchitis].
Li S; Chen Y; Tan P
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Oct; 20(5):299-300. PubMed ID: 10374457
[TBL] [Abstract][Full Text] [Related]
9. A comparison of a theophylline-ephedrine combination with terbutaline.
Bush RK; Smith AM; Welling PG; Alcala JC; Lee TP
Ann Allergy; 1978 Jul; 41(1):13-7. PubMed ID: 208429
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a short course of prednisolone with sustained-release theophylline in the control of nocturnal asthma.
Chhabra SK
Indian J Chest Dis Allied Sci; 1995; 37(1):7-14. PubMed ID: 16892732
[TBL] [Abstract][Full Text] [Related]
11. [Clinical effectiveness of a new preparation of sustained-release theophylline].
Corrias A; Pelosi U; Corona GB; Burrai P; Corda R
Pediatr Med Chir; 1989; 11(5):537-9. PubMed ID: 2631061
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
van der Vet AP; Drost RH; Kreukniet J; Maes RA
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
[TBL] [Abstract][Full Text] [Related]
13. Theophylline administration in children with asthma: optimal pulmonary function and possible tolerance to chronic administration.
Katz RM; Rachelefsky GS; Siegel SC; Mickey R
Ann Allergy; 1983 Jan; 50(1):23-6. PubMed ID: 6849515
[TBL] [Abstract][Full Text] [Related]
14. [Effect of slow-release theophylline on airway inflammation in bronchial asthma].
Adachi M; Minoguchi K; Mita S; Kokubu F; Suzuki H; Sano Y; Akiyama K; Yasuhara H
Arerugi; 1998 Aug; 47(8):734-43. PubMed ID: 9796114
[TBL] [Abstract][Full Text] [Related]
15. Use of a twelve-hour theophylline preparation in chronic adult asthmatics.
Tinkelman D; Vanderpool G; Carroll MS; Spangler DL
Ann Allergy; 1979 Sep; 43(3):155-9. PubMed ID: 573076
[TBL] [Abstract][Full Text] [Related]
16. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
Logvinoff MM; Weinstein DB; Watts MT; Seifert B
Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
Goldstein MF; Chervinsky P
Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
[TBL] [Abstract][Full Text] [Related]
18. The effects of oral and subcutaneous administration of terbutaline in asthmatic patients.
van den Berg W; Leferink JG; Maes RA; Fokkens JK; Kreukniet J; Bruynzeel PL
Eur J Respir Dis Suppl; 1984; 134():181-93. PubMed ID: 6327346
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment of children with sustained-release theophylline.
Pedersen S; Nathan E
Eur J Respir Dis; 1983 Nov; 64(8):564-70. PubMed ID: 6653683
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of plasma levels of 2 delayed-action theophyllines: Theostat 200 and Theodur 200, after a single evening dose].
Philip-Joet F; Bruguerolle B; Lagier F; Arnaud A
Rev Pneumol Clin; 1986; 42(6):279-83. PubMed ID: 3563255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
